The Enterprise Value as of June 2026 (TTM) for Oncolytics Biotech Inc. (ONCY) is 107.76M

According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 107.76M. This represents a change of -14.78% compared to the average of 126.45M of the last 4 quarters.

Oncolytics Biotech Inc. (ONCY) Historical Enterprise Value (quarterly & annually)

How has ONCY Enterprise Value performed in the past?

The mean historical Enterprise Value of Oncolytics Biotech Inc. over the last ten years is 79.20M. The current 107.76M Enterprise Value has changed 13.51% with respect to the historical average. Over the past ten years (40 quarters), ONCY's Enterprise Value was at its highest in in the December 2019 quarter at 207.87M. The Enterprise Value was at its lowest in in the September 2019 quarter at 5.39M.

Oncolytics Biotech Inc. (ONCY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oncolytics Biotech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oncolytics Biotech Inc. (ONCY) Average Enterprise Value

How has ONCY Enterprise Value performed in the past?

The current Enterprise Value of Oncolytics Biotech Inc. (ONCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oncolytics Biotech Inc. (ONCY) Enterprise Value vs. Peers

How is ONCY’s Enterprise Value compared to its peers?

Oncolytics Biotech Inc.’s Enterprise Value is greater than Atossa Therapeutics, Inc. (-10533885.00), less than Immix Biopharma, Inc. (381.48M), less than Whitehawk Therapeutics Inc (170.93M), greater than Instil Bio, Inc. (48.69M), less than Zentalis Pharmaceuticals, Inc. (269.67M), less than MacroGenics, Inc. (221.70M), greater than Tevogen Bio Holdings Inc. (46.22M), greater than Coya Therapeutics, Inc. (35.58M), greater than Clene Inc. (76.31M), greater than Surrozen, Inc. (74.76M),

Build a custom stock screener for Oncolytics Biotech Inc. (ONCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncolytics Biotech Inc. (ONCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.